Skip to content
healthcare.dev

Rhophylac

NDC 44206-300, HUMAN RHO(D) IMMUNE GLOBULIN, solution, from CSL Behring AG.

Product NDC
44206-300
Status
Listed
Labeler
CSL Behring AG
Dosage form
SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125070
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44206-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN RHO(D) IMMUNE GLOBULIN1500 [iU]/2mL

Pharmacologic classes

Endogenous Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
44206-300-01442060300011 SYRINGE, GLASS in 1 CARTON (44206-300-01) / 2 mL in 1 SYRINGE, GLASS (44206-300-90)
44206-300-104420603001010 SYRINGE, GLASS in 1 CARTON (44206-300-10) / 2 mL in 1 SYRINGE, GLASS (44206-300-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=44206-300

Use it

Look up 44206-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44206-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44206-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.